about
Histamine promotes the development of monocyte-derived dendritic cells and reduces tumor growth by targeting the myeloid NADPH oxidaseChanges in activation states of murine polymorphonuclear leukocytes (PMN) during inflammation: a comparison of bone marrow and peritoneal exudate PMN.Role of the ERK pathway for oxidant-induced parthanatos in human lymphocytes.Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia.NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance.Opposing effects of immunotherapy in melanoma using multisubtype interferon-alpha - can tumor immune escape after immunotherapy accelerate disease progression?Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemiaReactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells.Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia.Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.Immunotherapeutic strategies for relapse control in acute myeloid leukemia.A simple skin blister technique for the study of in vivo transmigration of human leukocytes.Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosisAddition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).TLR-Stimulated Neutrophils Instruct NK Cells To Trigger Dendritic Cell Maturation and Promote Adaptive T Cell Responses.Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells.The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface LigandsRole of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals.The anionic amphiphile SDS is an antagonist for the human neutrophil formyl peptide receptor 1.Activation of cytotoxic lymphocytes by interferon-alpha: role of oxygen radical-producing mononuclear phagocytes.Redox remodeling by dendritic cells protects antigen-specific T cells against oxidative stress.NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functions.Late divergence of survival curves in cancer immunotherapy trials: interpretation and implications.NOX2-dependent immunosuppression in chronic myelomonocytic leukemia.[Interferon-alpha can improve the prognosis in high-risk melanoma. Combination of surgery, cytostatics and natural IFN-alpha doubled the survival rate].CD20 antibodies induce production and release of reactive oxygen species by neutrophils.Chronic myeloid leukemic cells trigger poly(ADP-ribose) polymerase-dependent inactivation and cell death in lymphocytes.Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells.Dynamics of myeloid cell populations during relapse-preventive immunotherapy in acute myeloid leukemia.Analyzing cell death events in cultured leukocytes.Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2.Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid LeukemiaThe HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemiaCutting edge: Antioxidative properties of myeloid dendritic cells: protection of T cells and NK cells from oxygen radical-induced inactivation and apoptosisThe CD16-/CD56bright subset of NK cells is resistant to oxidant-induced cell deathHuman NK Cells induce neutrophil apoptosis via an NKp46- and Fas-dependent mechanism[Underutilization of anticancer agents--an example]
P50
Q28392943-970461D2-85E1-4384-93E1-7BDF198219DBQ34601549-A1E125BB-00AD-4D0E-87F2-D1ABEACD243AQ35107809-B7F8FFF6-124E-4E5C-AB3C-0636985527A1Q36597388-DB994750-C8BE-4BBA-B01F-55621A5DCA63Q36618933-446DD063-2E53-42DB-B215-AFDC09896EC4Q36821201-A4F1356A-65ED-4E4E-BF10-B4616E9C1B51Q36946572-35831F97-5FB7-46D0-894E-49E99B6A0E1CQ37362596-F1C2B2BE-3EA7-40FB-92D3-3F8290DD45E6Q37571981-CB9595F0-99FD-49B2-94E8-8AB517BA7AB9Q37810123-26849643-2539-4B7A-9582-A5D95E15E063Q38122868-81727BC0-48B7-410B-B088-7C6F6D951FA6Q38565708-365FB256-8B97-4266-8AAD-DC7B0ABD0B40Q38772230-04CA3FC1-68E5-4E29-A655-E36B86E4CB7CQ39355305-E03B8156-2B94-4CB4-ABE8-205FA6B74313Q40465372-E08A3571-8EF6-4BDB-9E2D-4CED284491E9Q40825087-361E9255-2B0E-4072-8FD1-77EC0AF0629FQ41527981-799EE511-8F52-4548-886B-C6080B78AFC2Q42146798-34A1ECAB-6A8C-46FD-B730-C073504C14DFQ42683573-D771EE6F-AC12-4EB7-AB24-64977AD0C4B8Q42987619-FD4C6E71-6617-49B3-B300-17EDD38AF909Q43098323-9DF9A589-1480-4478-9B7F-8ECD9898CEAFQ43460755-B9077F0D-CC9C-452A-B587-313CB15000BDQ43628074-AC90610C-E62F-401D-8C32-D454833C400BQ43682837-CEA7DCB3-077E-4F37-B6A0-9BFD1C596211Q45256176-B69F8DA7-23BA-4A0B-8B35-9C70A7546258Q46362738-2664A75C-F2ED-43E6-8B19-C9CD0EBB9B7DQ46404275-D0144BC6-9C60-4035-B0BA-CCE360B71819Q46671112-55A687D5-BD67-4AAC-96A2-6947B88F672BQ46876765-3338884F-3FA1-40AC-89BD-F9DDCB2700A6Q46904432-B567193C-A00F-4903-95EB-B2EAE0F3342CQ47809269-50E407A2-5BE2-4EC9-B725-1BD95977AEB3Q48691891-4011E6B9-1926-42F2-9FD4-10A4CDFE7072Q53190876-2B79BE24-2162-44AC-8F45-295A5A6DB7BEQ55397325-F4B7720B-976F-48CF-914B-B7C7B85D18A7Q59638379-A6B395B4-6385-48A2-AF81-DB7EAD02446BQ64105989-63CF2558-F59C-40EC-81AB-8EBAFD8AB1F0Q80499980-1FAD5162-10C8-4ACE-B925-CC0A42375D7FQ80582142-F7A39074-FBE9-4977-B356-6243426204CDQ83200615-15FA8E77-7D7C-468D-A5F8-FEB71F71F995Q83328725-3CE9BEA1-75E1-410F-A749-649009C55982
P50
description
Zweeds onderzoeker
@nl
hulumtues
@sq
researcher
@en
հետազոտող
@hy
name
Fredrik B Thorén
@nl
Fredrik B Thorén
@sl
Fredrik B. Thorén
@en
Fredrik B. Thorén
@es
type
label
Fredrik B Thorén
@nl
Fredrik B Thorén
@sl
Fredrik B. Thorén
@en
Fredrik B. Thorén
@es
altLabel
Fredrik Thoren
@en
prefLabel
Fredrik B Thorén
@nl
Fredrik B Thorén
@sl
Fredrik B. Thorén
@en
Fredrik B. Thorén
@es
P106
P1153
6507507159
P21
P27
P31
P3835
fredrik-thoren
P496
0000-0003-2167-7451